This HTML5 document contains 155 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://dx.doi.org/10.1038/
n4http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
n9https://scigraph.springernature.com/pub.10.1038/
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q45222030
rdf:type
wikibase:Item
schema:description
наукова стаття, опублікована в червні 2005 научна статия 2005年學術文章 scienca artikolo artículu científicu scientific article published in June 2005 2005年学术文章 บทความทางวิทยาศาสตร์ 2005年學術文章 vitskapeleg artikkel artigo científico 2005年學術文章 article científic bài báo khoa học научни чланак 2005年の論文 জুন ২০০৫-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 2005 nî lūn-bûn scientific article published in June 2005 videnskabelig artikel article scientifique 2005年學術文章 vědecký článek artikulong pang-agham 2005年學術文章 articol științific tieteellinen artikkeli artigo científico мақолаи илмӣ 2005年学术文章 مقالة علمية نشرت في يونيو 2005 bilimsel makale vetenskaplig artikel vedecký článok научная статья tudományos cikk scientific article published in June 2005 wetenschappelijk artikel artículo científico publicado en 2005 wissenschaftlicher Artikel 2005年学术文章 artykuł naukowy 2005年学术文章 artikull shkencor מאמר מדעי 2005年学术文章 naučni članak სამეცნიერო სტატია artikel ilmiah articolo scientifico artigo científico vitenskapelig artikkel 2005年学术文章 επιστημονικό άρθρο article scientific 2005년 논문 teaduslik artikkel научни чланак
p:P577
wds:Q45222030-8E4807F4-6B03-4032-A5C1-2A1BEEBB51F7
wdt:P577
2005-06-01T00:00:00Z
p:P2888
wds:Q45222030-9BB88B7D-900E-4D86-A32F-6CED815089D8
wdt:P2888
n9:sj.jhh.1001812
p:P2860
wds:Q45222030-A87D2DB3-D4AD-4243-B9E7-C9CBEB5C3A24 wds:Q45222030-ADCC6872-7758-487B-B316-239A68154D0A wds:Q45222030-A1B3D739-D714-4E90-B92C-62224BC5E5DF wds:Q45222030-979D08D1-080A-4293-AA55-28062E909238 wds:Q45222030-99B6EB44-7B1A-4A49-AF26-EE628CAEBE49 wds:Q45222030-890EB812-F95F-4FB5-8E24-14332D026686 wds:Q45222030-8B3ED1F5-AF97-4A41-932B-333FFB973244 wds:Q45222030-FF181F3D-1004-4212-AC26-9FD528872B81 wds:Q45222030-DA2166DC-A9AA-4551-9E98-02C5E4FB604B wds:Q45222030-E2E3F619-69C7-4C4A-A6B8-07F7D2F0653A wds:Q45222030-E605AB84-ADBF-4048-A33C-9D944D190EB3 wds:Q45222030-E7F9F9DD-280C-4433-AD8E-790F5E5BC26D wds:Q45222030-BF287DDC-0069-41E0-B6DC-E57BCC71DA7A wds:Q45222030-5493F67D-3F3C-4D16-B66C-C60D1B4225D9 wds:Q45222030-31518889-CF28-4CA6-9972-EA586226A657 wds:Q45222030-3E900599-43EA-49B0-A900-CCCD65D9E790 wds:Q45222030-471C801E-9322-4CEF-954E-AC74CDC60974 wds:Q45222030-4B06023B-81CA-48E8-8835-BD5A5BF37116 wds:Q45222030-2774DF74-6995-415C-88FA-81267BEA2792 wds:Q45222030-2D892BAC-4F42-4D34-84C2-EA66DB0365A1 wds:Q45222030-03E18D91-3946-4D8E-8494-5A8509EE29F1 wds:Q45222030-0ED26DAF-FC8C-48AA-A062-1328D5980E64
wdt:P2860
wd:Q44242786 wd:Q34331686 wd:Q43935480 wd:Q29615215 wd:Q29616306 wd:Q28204197 wd:Q74651672 wd:Q28144781 wd:Q28188162 wd:Q43897720 wd:Q43919591 wd:Q50985397 wd:Q51570195 wd:Q33897188 wd:Q44083504 wd:Q28188182 wd:Q44745068 wd:Q29547235 wd:Q74631559 wd:Q29617736 wd:Q44611131 wd:Q57830297
p:P2093
wds:Q45222030-6AE1C28E-84C5-42D4-A512-12DC01EB6F5E wds:Q45222030-5690105F-9842-4A76-9062-720ABE7FE97F wds:Q45222030-A698B9CE-D056-47C1-B2C2-E59D961A046B wds:Q45222030-B0B28AC7-3D33-4C69-AF56-AB124A471A4F wds:Q45222030-762046DD-0F06-42AF-80F8-FA477413F3D6 wds:Q45222030-9785FB36-E59C-4AF3-8BBE-0726CAA3A885
wdt:P2093
R A J M van Dijk R G Ijzerman J W R Twisk F J van Ittersum A Spoelstra-de Man M T Schram
rdfs:label
Aggressive antihypertensive therapy based on hydrochlorothiazide, candesartan or lisinopril as initial choice in hypertensive type II diabetic individuals: effects on albumin excretion, endothelial function and inflammation in a double-blind, random Aggressive antihypertensive therapy based on hydrochlorothiazide, candesartan or lisinopril as initial choice in hypertensive type II diabetic individuals: effects on albumin excretion, endothelial function and inflammation in a double-blind, random
skos:prefLabel
Aggressive antihypertensive therapy based on hydrochlorothiazide, candesartan or lisinopril as initial choice in hypertensive type II diabetic individuals: effects on albumin excretion, endothelial function and inflammation in a double-blind, random Aggressive antihypertensive therapy based on hydrochlorothiazide, candesartan or lisinopril as initial choice in hypertensive type II diabetic individuals: effects on albumin excretion, endothelial function and inflammation in a double-blind, random
schema:name
Aggressive antihypertensive therapy based on hydrochlorothiazide, candesartan or lisinopril as initial choice in hypertensive type II diabetic individuals: effects on albumin excretion, endothelial function and inflammation in a double-blind, random Aggressive antihypertensive therapy based on hydrochlorothiazide, candesartan or lisinopril as initial choice in hypertensive type II diabetic individuals: effects on albumin excretion, endothelial function and inflammation in a double-blind, random
p:P50
wds:Q45222030-2258FB5A-E66C-40B0-AEC8-EAFB42CC1541 wds:Q45222030-0050B8F4-0ED9-4A66-BEA7-5A38A5A99137
wdt:P50
wd:Q68596151 wd:Q76998834
p:P1476
wds:Q45222030-FE0DF135-BEBF-429B-8378-222F2582D206
wdt:P1476
Aggressive antihypertensive therapy based on hydrochlorothiazide, candesartan or lisinopril as initial choice in hypertensive type II diabetic individuals: effects on albumin excretion, endothelial function and inflammation in a double-blind, random
p:P304
wds:Q45222030-A834D69E-8ACE-4DBF-9E52-07AF74BFED5A
wdt:P304
429-437
p:P31
wds:Q45222030-1B17BE91-8AA7-4568-8969-3CA8B280EF92
wdt:P31
wd:Q13442814
p:P921
wds:Q45222030-300CDB8D-8192-48B6-87B8-A0D2836E8D61 wds:Q45222030-B17E2E3C-2A12-44AF-9639-EFED48DC3FF7
wdt:P921
wd:Q423930 wd:Q111140
p:P698
wds:Q45222030-BEAF5A67-E694-47D7-A133-DD9E868B2FFD
wdtn:P698
n4:15647778
wdt:P698
15647778
p:P1433
wds:Q45222030-9D1C3593-3274-4D77-91AA-396A36DE0553
wdt:P1433
wd:Q15746469
p:P433
wds:Q45222030-C9C4699B-22AC-4D91-A06B-7A26F483BB0C
p:P478
wds:Q45222030-1A03259F-15CD-40B4-B29E-C66C8624BEAC
wdt:P433
6
wdt:P478
19
p:P356
wds:Q45222030-92237E8F-51CF-4FED-A45A-522FD9216381
wdtn:P356
n12:SJ.JHH.1001812
wdt:P356
10.1038/SJ.JHH.1001812
p:P5875
wds:Q45222030-F91A78CD-E5CC-4DB3-90C4-9B3FDF6843D9
wdt:P5875
8083186
p:P6179
wds:Q45222030-6E4223CD-688D-42E8-B518-9AD2917F20F9
wdt:P6179
1034789356